Epitalon — Research Reference

Epitalon (also spelled Epithalon or Epithalone; chemical name Ala-Glu-Asp-Gly) is a synthetic tetrapeptide (4 amino acids) developed by the St. Petersburg Institute of Bioregulation and Gerontology, primarily through the research of Professor Vladimir Khavinson. It is described as a synthetic analogue of epithalamin, a natural polypeptide extract from the pineal gland.

Research on Epitalon has primarily been conducted in Russia and has focused on longevity, telomerase activation, sleep regulation, and antioxidant activity.

Quick Reference

Overview

Epitalon is derived from research into the role of the pineal gland in ageing and neuroendocrine regulation. The hypothesis underlying Epitalon research is that the pineal gland produces regulatory peptides that influence the rate of biological ageing, and that Epitalon may partially replicate this regulatory activity.

Research has investigated Epitalon for its potential role in:

• Telomerase activation: A key area of research. Published studies have reported that Epitalon activates telomerase (hTERT) and promotes telomere elongation in human somatic cells and lymphocytes in vitro — a finding of significant interest given the association between telomere length and cellular senescence.
• Melatonin regulation: Research has investigated Epitalon’s potential to restore age-related decline in pineal melatonin production, which is associated with disrupted sleep-wake cycles in older populations.
• Antioxidant activity: Studies in animal models have reported reduced markers of oxidative stress following Epitalon administration.
• Lifespan extension: Animal research (rodents, fruit flies) has reported modest lifespan extension in several experimental models.
• Cancer cell suppression: Some published research has investigated Epitalon for potential inhibitory effects on tumour cell growth in animal and in vitro models — though this remains a preliminary and contested research area.

Epitalon is not approved for human therapeutic use in any major Western jurisdiction and is classified as a research compound. Some Russian research products have used it in clinical settings as part of broader bioregulatory peptide research programmes.

Reported Protocols

The following information represents commonly reported research ranges drawn from anecdotal accounts and published research literature. These are not medical recommendations.

Subcutaneous Protocol

Subcutaneous injection is the most commonly reported administration route in research accounts. Commonly reported doses range from 5 mg to 10 mg per day, administered for defined cycle periods rather than continuously.

• Cycle length: Commonly reported cycles of 10–20 consecutive days are the predominant protocol structure in both published research and anecdotal accounts
• Cycle frequency: Anecdotal research accounts describe 1–2 cycles per year, or cycles spaced 4–6 months apart. Some accounts describe one cycle per year as a longevity-focused approach
• Frequency within cycle: Once daily injection is the most commonly reported approach during the active cycle

Intramuscular Protocol

Intramuscular injection is also reported in research contexts, particularly in Russian clinical research publications. The dose range is similar to the subcutaneous protocol.

Intranasal Protocol

Intranasal administration of Epitalon is less commonly reported than parenteral routes. Anecdotal accounts describe nasal spray preparations at doses of 5–10 mg per day, used as an alternative for those who prefer to avoid injection.

Reported Effects

The following effects have been reported in research literature and anecdotal accounts. This list reflects the research landscape, not confirmed clinical outcomes in general populations.

Telomere Length and Telomerase Activity

The most scientifically cited area of Epitalon research concerns telomere biology. Published in vitro studies have reported that Epitalon activates telomerase in human cells and produces measurable telomere elongation. The significance of this finding for whole-organism ageing in humans is not yet established, but represents a primary rationale for longevity-focused research interest.

Melatonin and Sleep Regulation

Research has investigated Epitalon for its potential role in restoring declining pineal melatonin secretion associated with ageing. Anecdotal reports frequently describe improved sleep quality during and following Epitalon research cycles, particularly in older individuals. Animal research has reported restoration of age-related circadian rhythm disruption.

Antioxidant Effects

Animal research has reported reductions in markers of oxidative stress following Epitalon administration, including reduced lipid peroxidation products and improved antioxidant enzyme activity. This is proposed as a potential mechanism underlying some of the reported longevity effects in animal models.

Lifespan Effects in Animal Models

Studies in rodents have reported modest (approximately 10–16%) increases in lifespan in some experimental cohorts receiving Epitalon. These findings form part of the animal evidence base reviewed by longevity researchers, though extrapolation to human ageing requires caution.

Reported Subjective Effects

Anecdotal research accounts frequently describe improved sleep quality, improved sense of wellbeing, and occasionally improved skin quality. These subjective reports are not corroborated by controlled human trial data.

Reported Side Effects

Reported side effects in research and anecdotal accounts include the following. This list does not constitute a comprehensive safety profile and should not be interpreted as predictive of individual outcomes.

Epitalon is generally reported in anecdotal accounts as well tolerated with a low apparent side effect burden. The short half-life and limited systemic exposure from a tetrapeptide at research doses are considered factors in the favourable tolerability profile. However, the compound has not undergone comprehensive human safety trials in controlled research chemical contexts.

Storage & Handling

Lyophilized Powder (Unreconstituted)

• Room temperature: Reported stable for up to 3 months when kept away from light and moisture
• Refrigerator (2–8°C): Preferred for extended storage; commonly reported stable for 12 months or more
• Freezer: Acceptable for long-term storage; avoid repeated freeze-thaw cycles
• Light sensitivity: Protect from light; store in an opaque or amber vial

Reconstituted Solution

• Refrigerator (2–8°C): Use within 4–6 weeks of reconstitution
• Do not freeze a reconstituted solution
• Bacteriostatic water (BAC water) is the standard diluent for multi-use vials
• Discard if the solution becomes cloudy, discoloured, or shows particulate matter

Reconstitution

Add bacteriostatic water slowly along the inside wall of the vial. Swirl gently — do not shake. See the Reconstitution Guide for step-by-step instructions.

Frequently Asked Questions

What is the evidence that Epitalon activates telomerase? The primary published evidence comes from in vitro studies conducted by Khavinson and colleagues, which reported that Epitalon activated telomerase in human fetal fibroblast and lymphocyte cell cultures and produced measurable telomere elongation. These findings have not been independently replicated at scale, and the in vivo relevance for human longevity remains speculative. The research is considered preliminary but has generated sustained interest in the longevity research community.

How often should Epitalon be cycled? Commonly reported research protocols describe 1–2 cycles per year, each lasting 10–20 days. The rationale for infrequent cycling is that the desired biological effects (particularly any telomere-related effects) are expected to persist following the treatment period. Daily continuous use is not the standard approach in the research literature.

Is Epitalon the same as epithalamin? Epithalamin is a natural polypeptide extract from bovine pineal gland tissue. Epitalon is a synthetic tetrapeptide proposed to represent the active sequence within epithalamin. The two are related but distinct compounds. Epitalon is the more commonly researched and available form.

Does Epitalon improve sleep in younger individuals? The published research on melatonin restoration and sleep has primarily focused on older populations with age-related sleep disruption. Anecdotal reports from younger researchers describe improved sleep depth and quality, but the mechanism — if any — would differ from the pineal restoration hypothesis relevant to older individuals.

Related Pages

Goals: Longevity · Sleep

Class: Longevity Peptides

Comparisons: Epitalon vs NAD+ · Epitalon vs MOTS-c

References & Further Reading

• Khavinson VK, et al. (2003). Epithalon peptide induces telomerase activity and telomere elongation in human somatic cells. Neoplasma, 50(3), 228–232. PubMed →
• Anisimov VN, et al. (2001). Effect of Epitalon on biomarkers of aging, life span and spontaneous tumor incidence in female Swiss-derived SHR mice. Biogerontology, 2(2), 141–147. PubMed →
• Khavinson VK, Morozov VG. (2003). Peptides of pineal gland and thymus prolong human life. Neuroendocrinology Letters, 24(3–4), 233–240. PubMed →